Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06790641 · ClinicalTrials.gov registry record · NA

Pathways to Perinatal Mental Health Equity

A NA study of Substance Use Disorder (SUD) and Perinatal Depression, sponsored by University of Massachusetts, Worcester.

Recruiting
Registry status
NA
Development phase
1,270
Enrollment target
1
Study location

NCT06790641: Recruiting NA study of Substance Use Disorder (SUD) and Perinatal Depression, sponsored by University of Massachusetts, Worcester.

NCT06790641 is a NA study of Substance Use Disorder (SUD) and Perinatal Depression that is actively recruiting participants, run by University of Massachusetts, Worcester. The registered enrollment target is 1,270 participants, above the 164-participant average among 15 other Substance Use Disorder (SUD) trials with a reported enrollment target (674% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06790641, a NA study of Substance Use Disorder (SUD) and Perinatal Depression, is actively recruiting participants, sponsored by University of Massachusetts, Worcester.

RECRUITING
Registry status
NA
Development phase
1,270 participants
Enrollment target
1
Study location

Study Summary

Mental health conditions occurring during pregnancy and up to one year postpartum (the perinatal period) occur in 1 in 5 perinatal individuals. To improve mental health care during the perinatal period, this study will implement and compare a health care model of improving mood and anxiety disorder care in practices with a health care-community partnership model. The study will include 32 perinatal care settings across the United States. Half of them will have the health care model, the other half will have the health care-community partnership model. The study is designed to answer the question, "Should states and healthcare systems put resources into a healthcare system approach or a healthcare-community partnership approach to mental health care?" The results of this study will help states and healthcare systems decide how to develop pathways for increasing access to mental health care for pregnant and postpartum individuals.

Primary Outcome

Perinatal individual depressive symptoms will be determined from their medical charts, through the screening questionnaire used by their care setting. The screener may be the Edinburgh Postnatal Depression Scale (EPDS) or the Patient Health Questionnaire-9 (PHQ-9). The 10-item EPDS is the most widely used measure of perinatal depression symptoms. The 9-item PHQ-9 is the most widely-used measure of depression symptoms across the lifespan and the second most widely used measure during the perinata

Conditions Studied

Substance Use Disorder (SUD) Perinatal Depression Social Determinants of Health (SDOH) Perinatal Anxiety Peer Support Obstetric Care Perinatal Depression, Substance Use

Interventions

  • BEHAVIORAL Program in Support of Moms (PRISM)
  • BEHAVIORAL PSI Peer Support

Study Locations (1)

Massachusetts

  • UMass Chan Medical School - Shrewsbury

Trial Details

FieldValue
Enrollment Target 1,270 participants
Start Date 2025-12-05
Est. Completion 2030-10-01
Phase NA
University of Massachusetts, Worcester

240 total trials

What NCT06790641 shows while recruiting

NCT06790641 is an interventional study that assigns participants to a tested intervention. Its 1,270 participants enrollment target places it among the larger protocols in the corpus, above the 164-participant average among 15 other Substance Use Disorder (SUD) trials with a reported enrollment target (674% higher).

The record links to 7 conditions, with Substance Use Disorder (SUD) appearing as the primary indexed condition, and to 2 interventions - of which Program in Support of Moms (PRISM) is the first listed.

NCT06790641 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06790641 about?

NCT06790641 is a clinical study titled "Pathways to Perinatal Mental Health Equity". Mental health conditions occurring during pregnancy and up to one year postpartum (the perinatal period) occur in 1 in 5 perinatal individuals. To improve mental health care during the perinatal period, this study will implement and compare a health care model of improving mood and anxiety disorder ...

What is the current status of trial NCT06790641?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,270 participants. The study started on 2025-12-05. Estimated completion is 2030-10-01.

What conditions does trial NCT06790641 study?

This clinical trial studies the following conditions: Substance Use Disorder (SUD), Perinatal Depression, Social Determinants of Health (SDOH), Perinatal Anxiety, Peer Support.

What interventions are being tested in trial NCT06790641?

The interventions under investigation include: Program in Support of Moms (PRISM) (BEHAVIORAL), PSI Peer Support (BEHAVIORAL).

Who is sponsoring clinical trial NCT06790641?

This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06790641 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Substance Use Disorder (SUD)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06790641's enrollment target sits among peer trials

1,270 1st of 15 higher than 15 of 15 other Substance Use Disorder (SUD) trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Substance Use Disorder (SUD) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06876246 · 1,270 participants · NA

    SBIR/ STTR Family Check-up Online

  • NCT03678025 · 1,273 participants · Phase 3

    Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

  • NCT07225504 · 1,275 participants · Phase 3

    A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  • NCT07001800 · 1,276 participants · Phase 2

    Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06790641

Source: ClinicalTrials.gov NCT06790641, the US trial registry maintained by the National Library of Medicine. NCT06790641 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.